Skip to content
August 14, 2022

Equity.Guru

Investment information for the new generation

trichome financial

CANN focuses on extraction and the creation of derivative products for recreational and medical consumers….
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”…
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate…
Heritage is positioning itself to radically expand its sales territory….
Trichome Financial (TFC.C) and Auxly Cannabis Group (XLY.V) agreed to an $8 million debt facility today, according to a press release. The financial allotment will be available to several…
At a time when some cannabis companies have taken to borrowing money at rates as high as 55%, you’ve got to hand it to any crew that, in the…
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”….
Gross revenue was $1.4-million in the second quarter of 2020, compared with nil in the three-month period ended April 30, 2019….
“In a sector rife with terrible CEOs that have wasted company treasury and goodwill…none come close to Bierman in terms of self enrichment, entitlement, and outward facing douchery,” wrote…
New licenses, deals, products – that’s all good – but it’s not the nitty gritty stuff investors are looking for now. By “nitty-gritty” we mean – numbers. Four weeks ago, Heritage…